US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6096331A
(en)
*
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
US6179817B1
(en)
|
1995-02-22 |
2001-01-30 |
Boston Scientific Corporation |
Hybrid coating for medical devices
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
SI0932399T1
(sl)
*
|
1996-03-12 |
2006-10-31 |
Pg Txl Co Lp |
Vodotopna paklitakselna predzdravila
|
ATE310538T1
(de)
*
|
1996-04-15 |
2005-12-15 |
Asahi Chemical Ind |
Arzneimittelkomplexe enthaltend taxan- verbindungen oder steroiden
|
US6030941A
(en)
*
|
1996-05-01 |
2000-02-29 |
Avi Biopharma, Inc. |
Polymer composition for delivering substances in living organisms
|
EP0966303A2
(de)
*
|
1996-05-01 |
1999-12-29 |
Antivirals Inc. |
Polypeptidkonjugate zum transport von substanzen durch zellmembranen
|
WO1997045105A1
(en)
*
|
1996-05-24 |
1997-12-04 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing diseases of body passageways
|
US8137684B2
(en)
*
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
GB9708265D0
(en)
*
|
1997-04-24 |
1997-06-18 |
Nycomed Imaging As |
Contrast agents
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
US20030157187A1
(en)
*
|
1996-12-02 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing inflammatory diseases
|
US6204388B1
(en)
|
1996-12-03 |
2001-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
EP0977563B1
(de)
|
1996-12-03 |
2005-10-12 |
Sloan-Kettering Institute For Cancer Research |
Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US7112338B2
(en)
*
|
1997-03-12 |
2006-09-26 |
The Regents Of The University Of California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
DE19718339A1
(de)
*
|
1997-04-30 |
1998-11-12 |
Schering Ag |
Polymer beschichtete Stents, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
BR9809138A
(pt)
|
1997-05-21 |
2001-08-28 |
Trustees For The Leland Stanfo |
Conjugado e método para aumentar o transporte de um composto selecionado atravessando uma membrana biológica
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
US6306166B1
(en)
*
|
1997-08-13 |
2001-10-23 |
Scimed Life Systems, Inc. |
Loading and release of water-insoluble drugs
|
DE19744135C1
(de)
*
|
1997-09-29 |
1999-03-25 |
Schering Ag |
Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
US20040170563A1
(en)
*
|
1997-10-27 |
2004-09-02 |
Meade Thomas J. |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
US6485514B1
(en)
*
|
1997-12-12 |
2002-11-26 |
Supergen, Inc. |
Local delivery of therapeutic agents
|
US6394945B1
(en)
*
|
1997-12-22 |
2002-05-28 |
Mds (Canada), Inc. |
Radioactively coated devices
|
CA2315693C
(en)
*
|
1997-12-22 |
2010-11-30 |
Schering Corporation |
Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
|
KR100228187B1
(ko)
*
|
1997-12-24 |
1999-11-01 |
김성년 |
풍선도자 기구에 사용되는 방사성 밸룬 및 그의 제조방법
|
CA2281937A1
(en)
*
|
1997-12-25 |
1999-07-08 |
Toray Industries, Inc. |
Drug for treating abnormalities in bone marrow
|
US6683100B2
(en)
|
1999-01-19 |
2004-01-27 |
Novartis Ag |
Organic compounds
|
JP4644364B2
(ja)
*
|
1998-02-05 |
2011-03-02 |
ノバルティス アーゲー |
エポシロン組成物
|
GB9802451D0
(en)
*
|
1998-02-05 |
1998-04-01 |
Ciba Geigy Ag |
Organic compounds
|
US7030155B2
(en)
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
CA2335842A1
(en)
*
|
1998-06-26 |
2000-01-06 |
Quanam Medical Corporation |
Topoisomerase inhibitors for prevention of restenosis
|
US5981564A
(en)
*
|
1998-07-01 |
1999-11-09 |
Universite Laval |
Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
US7008645B2
(en)
|
1998-07-14 |
2006-03-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inhibiting restenosis using bisphosphonates
|
US6984400B2
(en)
|
1998-07-14 |
2006-01-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of treating restenosis using bisphosphonate nanoparticles
|
IL125336A0
(en)
*
|
1998-07-14 |
1999-03-12 |
Yissum Res Dev Co |
Compositions for inhibition and treatment of restinosis
|
CA2340652C
(en)
|
1998-08-20 |
2013-09-24 |
Cook Incorporated |
Coated implantable medical device comprising paclitaxel
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
DE19845798A1
(de)
*
|
1998-09-29 |
2000-04-13 |
Schering Ag |
Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
|
WO2000041687A2
(en)
*
|
1999-01-12 |
2000-07-20 |
Quanam Medical Corporation |
Composition and methods for administration of water-insoluble paclitaxel derivatives
|
US6333347B1
(en)
|
1999-01-29 |
2001-12-25 |
Angiotech Pharmaceuticals & Advanced Research Tech |
Intrapericardial delivery of anti-microtubule agents
|
CN1344156A
(zh)
*
|
1999-02-23 |
2002-04-10 |
血管技术药物公司 |
用于改善身体通道和腔完整性的组合物及方法
|
US7018654B2
(en)
*
|
1999-03-05 |
2006-03-28 |
New River Pharmaceuticals Inc. |
Pharmaceutical composition containing an active agent in an amino acid copolymer structure
|
US6716452B1
(en)
*
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US7060708B2
(en)
|
1999-03-10 |
2006-06-13 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US20040121954A1
(en)
*
|
1999-04-13 |
2004-06-24 |
Xu Wuhan Jingya |
Poly(dipeptide) as a drug carrier
|
US20010041189A1
(en)
*
|
1999-04-13 |
2001-11-15 |
Jingya Xu |
Poly(dipeptide) as a drug carrier
|
US6317615B1
(en)
|
1999-04-19 |
2001-11-13 |
Cardiac Pacemakers, Inc. |
Method and system for reducing arterial restenosis in the presence of an intravascular stent
|
US6368658B1
(en)
*
|
1999-04-19 |
2002-04-09 |
Scimed Life Systems, Inc. |
Coating medical devices using air suspension
|
US7029653B1
(en)
*
|
1999-06-21 |
2006-04-18 |
Nihon Medi-Physics Co., Ltd. |
Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method
|
US6258121B1
(en)
*
|
1999-07-02 |
2001-07-10 |
Scimed Life Systems, Inc. |
Stent coating
|
US6273901B1
(en)
*
|
1999-08-10 |
2001-08-14 |
Scimed Life Systems, Inc. |
Thrombosis filter having a surface treatment
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
US7229961B2
(en)
*
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
AU769315B2
(en)
|
1999-08-24 |
2004-01-22 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
ES2258471T3
(es)
*
|
1999-09-09 |
2006-09-01 |
The Regents Of The University Of California |
Suministro de liposomas cationicos de taxanos a vasos sanguineos angiogenicos.
|
CN1111166C
(zh)
*
|
1999-09-10 |
2003-06-11 |
云南汉德生物技术有限公司 |
水溶性三尖杉磷碱聚氨基酸酯或其盐,含它们的药物组合物及其医药用途
|
US6380405B1
(en)
|
1999-09-13 |
2002-04-30 |
Nobex Corporation |
Taxane prodrugs
|
US6541508B2
(en)
|
1999-09-13 |
2003-04-01 |
Nobex Corporation |
Taxane prodrugs
|
US6713454B1
(en)
*
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
HUP0203123A3
(en)
*
|
1999-10-12 |
2004-12-28 |
Cell Therapeutics Inc Seattle |
Process for preparation of polyglutamate-therapeutic agent conjugates
|
US20030054977A1
(en)
*
|
1999-10-12 |
2003-03-20 |
Cell Therapeutics, Inc. |
Manufacture of polyglutamate-therapeutic agent conjugates
|
US7067111B1
(en)
|
1999-10-25 |
2006-06-27 |
Board Of Regents, University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
US6692724B1
(en)
|
1999-10-25 |
2004-02-17 |
Board Of Regents, The University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
US6638906B1
(en)
|
1999-12-13 |
2003-10-28 |
Nobex Corporation |
Amphiphilic polymers and polypeptide conjugates comprising same
|
US6313143B1
(en)
*
|
1999-12-16 |
2001-11-06 |
Hoffmann-La Roche Inc. |
Substituted pyrroles
|
US20020077290A1
(en)
*
|
2000-03-17 |
2002-06-20 |
Rama Bhatt |
Polyglutamic acid-camptothecin conjugates and methods of preparation
|
CA2402643A1
(en)
*
|
2000-03-17 |
2001-09-27 |
Cell Therapeutics, Inc. |
Polyglutamic acid-camptothecin conjugates and methods of preparation
|
US6362217B2
(en)
*
|
2000-03-17 |
2002-03-26 |
Bristol-Myers Squibb Company |
Taxane anticancer agents
|
US8101200B2
(en)
|
2000-04-13 |
2012-01-24 |
Angiotech Biocoatings, Inc. |
Targeted therapeutic agent release devices and methods of making and using the same
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
US8236048B2
(en)
|
2000-05-12 |
2012-08-07 |
Cordis Corporation |
Drug/drug delivery systems for the prevention and treatment of vascular disease
|
DK1286704T3
(da)
|
2000-06-02 |
2014-09-22 |
Univ Texas |
Ethylendicystein (EC)-glucose analoge konjugater
|
WO2001098286A1
(en)
|
2000-06-22 |
2001-12-27 |
Nitromed, Inc. |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
CN1125097C
(zh)
*
|
2000-07-05 |
2003-10-22 |
天津大学 |
聚乙二醇支载的紫杉醇或多烯紫杉醇的前药
|
US20020099013A1
(en)
*
|
2000-11-14 |
2002-07-25 |
Thomas Piccariello |
Active agent delivery systems and methods for protecting and administering active agents
|
US7163918B2
(en)
|
2000-08-22 |
2007-01-16 |
New River Pharmaceuticals Inc. |
Iodothyronine compositions
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
MXPA03002871A
(es)
|
2000-09-29 |
2004-12-06 |
Johnson & Johnson |
Dispositivos medicos recubiertos.
|
US7803149B2
(en)
|
2002-07-12 |
2010-09-28 |
Cook Incorporated |
Coated medical device
|
US6616592B1
(en)
*
|
2000-11-13 |
2003-09-09 |
Isotech, L.L.C. |
Radioactive medical devices for inhibiting a hyperplastic response and method of making radioactive medical devices
|
US6612976B2
(en)
*
|
2000-11-13 |
2003-09-02 |
Isotech, L.L.C. |
Radioactive medical devices and methods of making radioactive medical devices
|
US8394813B2
(en)
|
2000-11-14 |
2013-03-12 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
US20090306228A1
(en)
*
|
2000-11-14 |
2009-12-10 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
JP2006516948A
(ja)
*
|
2000-11-14 |
2006-07-13 |
ニュー リバー ファーマシューティカルズ インコーポレイテッド |
硫酸アバカビルを含有する新規な薬剤化合物および同化合物の製造ならびに使用方法
|
WO2002041931A2
(en)
*
|
2000-11-27 |
2002-05-30 |
Medtronic, Inc. |
Stents and methods for preparing stents
|
CA2432797C
(en)
*
|
2000-12-18 |
2014-02-04 |
David J. Yang |
Local regional chemotherapy and radiotherapy using in situ hydrogel
|
ES2236481T3
(es)
*
|
2001-01-16 |
2005-07-16 |
Glaxo Group Limited |
Combinacion farmaceutica que contiene una 4-quinazolinamina y paclitaxel, carboplatino o vinorelbina para el tratamiento de cancer.
|
CA2435418A1
(en)
*
|
2001-01-24 |
2002-08-01 |
Mestex Ag |
Use of neurotoxic substances in producing a medicament for treating joint pains
|
NZ526871A
(en)
*
|
2001-01-25 |
2006-01-27 |
Bristol Myers Squibb Co |
Pharmaceutical dosage forms of epothilones for oral administration
|
HUP0302567A2
(hu)
|
2001-01-25 |
2003-12-29 |
Bristol-Myers Squibb Co. |
Epotilon analógokat tartalmazó parenterális adagolási formák és eljárás az előállításukra
|
US7771468B2
(en)
*
|
2001-03-16 |
2010-08-10 |
Angiotech Biocoatings Corp. |
Medicated stent having multi-layer polymer coating
|
IL157333A0
(en)
*
|
2001-03-19 |
2004-02-19 |
Novartis Ag |
Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
|
US20020169125A1
(en)
*
|
2001-03-21 |
2002-11-14 |
Cell Therapeutics, Inc. |
Recombinant production of polyanionic polymers and uses thereof
|
DE10115740A1
(de)
*
|
2001-03-26 |
2002-10-02 |
Ulrich Speck |
Zubereitung für die Restenoseprophylaxe
|
EP1389090A2
(de)
*
|
2001-04-26 |
2004-02-18 |
Board of Regents, The University of Texas System |
Diagnostische bildgebende zusammensetzungen, ihre syntheseverfahren und ihre verwendung
|
WO2002090390A1
(en)
*
|
2001-05-04 |
2002-11-14 |
University Of Utah Research Foundation |
Hyaluronic acid containing bioconjugates : targeted delivery of anti-cancer drugs to cancer cells
|
US7338939B2
(en)
*
|
2003-09-30 |
2008-03-04 |
New River Pharmaceuticals Inc. |
Abuse-resistant hydrocodone compounds
|
US20070066537A1
(en)
*
|
2002-02-22 |
2007-03-22 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US7169752B2
(en)
|
2003-09-30 |
2007-01-30 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US20060014697A1
(en)
|
2001-08-22 |
2006-01-19 |
Travis Mickle |
Pharmaceutical compositions for prevention of overdose or abuse
|
US7375082B2
(en)
*
|
2002-02-22 |
2008-05-20 |
Shire Llc |
Abuse-resistant hydrocodone compounds
|
US7708712B2
(en)
*
|
2001-09-04 |
2010-05-04 |
Broncus Technologies, Inc. |
Methods and devices for maintaining patency of surgically created channels in a body organ
|
EP1429819B1
(de)
*
|
2001-09-24 |
2010-11-24 |
Boston Scientific Limited |
Optimierte dosierung bei paclitaxelhaltigen stents
|
CA2464346A1
(en)
*
|
2001-10-30 |
2003-05-08 |
Nektar Therapeutics Al, Corporation |
Water-soluble polymer conjugates of retinoic acid
|
US7488313B2
(en)
*
|
2001-11-29 |
2009-02-10 |
Boston Scientific Scimed, Inc. |
Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment
|
DE10158904A1
(de)
*
|
2001-11-30 |
2003-06-12 |
Roche Diagnostics Gmbh |
Verfahren zur Herstellung von linearen DNA Fragmenten für die in vitro Expression von Proteinen
|
KR20030049023A
(ko)
*
|
2001-12-13 |
2003-06-25 |
주식회사 코오롱 |
방사선 감작제용 파클리탁셀 유도체
|
CN1273130C
(zh)
*
|
2001-12-20 |
2006-09-06 |
布里斯托尔-迈尔斯斯奎布公司 |
具有增大的生物利用率的口服活性紫杉烷衍生物的药物组合物
|
US7261875B2
(en)
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
US7838619B2
(en)
*
|
2002-01-14 |
2010-11-23 |
The General Hospital Corporation |
Biodegradable polyketal polymers and methods for their formation and use
|
KR20030068955A
(ko)
*
|
2002-02-19 |
2003-08-25 |
주식회사 코오롱 |
새로운 중간 결합체(self-immolatinglinker) 화합물과 그 제조방법, 이를 이용한파클리탁셀 또는 이의 유도체의 잔기를 포함하는 수용성프로드럭 화합물, 그의 제조방법 및 이를 유효성분으로포함하는 약제 조성물
|
CN1650024A
(zh)
*
|
2002-02-22 |
2005-08-03 |
新河药品股份有限公司 |
应用肽-药物的结合减少受试者间药物血清水平的变异
|
US7700561B2
(en)
*
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
US7659253B2
(en)
|
2002-02-22 |
2010-02-09 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
US7105486B2
(en)
*
|
2002-02-22 |
2006-09-12 |
New River Pharmaceuticals Inc. |
Abuse-resistant amphetamine compounds
|
CA2477004C
(en)
*
|
2002-02-22 |
2011-05-10 |
Thomas Piccariello |
Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
|
CA2476589C
(en)
*
|
2002-02-27 |
2014-02-25 |
Pharmain, Ltd. |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
CN100475269C
(zh)
*
|
2002-03-05 |
2009-04-08 |
北京键凯科技有限公司 |
亲水性聚合物-谷氨酸寡肽与药物分子的结合物、包含该结合物的组合物及用途
|
DE10209822A1
(de)
*
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
|
DE10209821A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
DE60315145T2
(de)
*
|
2002-03-13 |
2008-04-30 |
Beijing Jiankai Technology Co., Ltd. |
Hydrophiles polymerderivat mit y-verzweigung und herstellungsverfahren dafür; obige verbindung enthaltender medizinischer verbundwerkstoff
|
AU2003236076A1
(en)
*
|
2002-03-22 |
2003-10-08 |
Beijing Jiankai Technology Co., Ltd. |
Hydrophilic polymers-flavonoids conjugates and pharmaceutical compositions comprising them
|
US7264822B2
(en)
*
|
2002-04-03 |
2007-09-04 |
Poly-Med, Inc. |
Conjugated drug-polymer coated stent
|
KR20050043796A
(ko)
*
|
2002-05-20 |
2005-05-11 |
코산 바이오사이언시즈, 인코포레이티드 |
에포틸론 d의 투여방법
|
CN1759115A
(zh)
|
2002-08-23 |
2006-04-12 |
索隆-基特林癌症研究协会 |
埃坡霉素(epothilone),合成埃坡霉素的中间体,其类似物及其用途
|
US7649006B2
(en)
|
2002-08-23 |
2010-01-19 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US20040047835A1
(en)
*
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
PT1534340E
(pt)
|
2002-09-06 |
2012-03-13 |
Cerulean Pharma Inc |
Polímeros à base de ciclodextrina para a administração de medicamentos ligados por ligação covalente
|
AU2003253399B2
(en)
*
|
2002-09-11 |
2010-10-14 |
Fresenius Kabi Deutschland Gmbh |
Hasylated polypeptides, especially hasylated erythropoietin
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
ITPD20020271A1
(it)
|
2002-10-18 |
2004-04-19 |
Fidia Farmaceutici |
Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
|
US7326421B2
(en)
*
|
2002-10-21 |
2008-02-05 |
Kensey Nash Corporation |
Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues
|
EP1562641A4
(de)
*
|
2002-11-07 |
2008-12-03 |
Univ Texas |
Ethylendicystein(ec)-arzneimittelkonjugate, zusammensetzungen und verfahren für die gewebsspezifische darstellung von krankheiten
|
US20040152708A1
(en)
|
2002-11-07 |
2004-08-05 |
Yong Li |
Trans-9,10-dehydroepothilone C and D, analogs thereof and methods of making the same
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
WO2004063195A1
(en)
*
|
2003-01-03 |
2004-07-29 |
Sloan-Kettering Institute For Cancer Research |
Pyridopyrimidine kinase inhibitors
|
EP1596825A2
(de)
|
2003-02-03 |
2005-11-23 |
Neopharm, Inc. |
Stabiles steriles filtrierbares liposom-enkapsuliertes taxan und andere antineoplastische wirkstoffe
|
US7311727B2
(en)
*
|
2003-02-05 |
2007-12-25 |
Board Of Trustees Of The University Of Arkansas |
Encased stent
|
PL1604687T3
(pl)
*
|
2003-03-20 |
2011-04-29 |
Nippon Kayaku Kk |
Preparat micelarny zawierający słabo rozpuszczalny w wodzie lek przeciwnowotworowy oraz nowy kopolimer blokowy
|
US7306580B2
(en)
*
|
2003-04-16 |
2007-12-11 |
Cook Incorporated |
Medical device with therapeutic agents
|
KR100512483B1
(ko)
|
2003-05-07 |
2005-09-05 |
선바이오(주) |
신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법
|
EP1475105A1
(de)
*
|
2003-05-09 |
2004-11-10 |
Schering AG |
Knochengewebegerichtetes Radiopharmaceuticum und Tubulin-interagierende Verbindung kombinatorischer Radiotherapie
|
TW200427503A
(en)
*
|
2003-05-27 |
2004-12-16 |
Kureha Chemical Ind Co Ltd |
Process for producing thermoplastic resin molding
|
SI1644019T2
(en)
|
2003-05-29 |
2018-04-30 |
Shire Llc |
AMPHETAMINE COMPOUNDS COMPOUNDS TO ABUSE
|
US7691838B2
(en)
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
DE10324710A1
(de)
|
2003-05-30 |
2004-12-16 |
Supramol Parenteral Colloids Gmbh |
Stärkederivatkomplexe
|
US20050026893A1
(en)
*
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
US20050020534A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites
|
US20050020556A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
|
US20050054589A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics
|
US20050054625A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
|
US20050020557A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
|
US10517883B2
(en)
|
2003-06-27 |
2019-12-31 |
Zuli Holdings Ltd. |
Method of treating acute myocardial infarction
|
WO2005014655A2
(en)
*
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
US20080274948A1
(en)
*
|
2003-08-08 |
2008-11-06 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of Hydroxyalkyl Starch and G-Csf
|
US20050152979A1
(en)
*
|
2003-09-05 |
2005-07-14 |
Cell Therapeutics, Inc. |
Hydrophobic drug compositions containing reconstitution enhancer
|
ATE507845T1
(de)
|
2003-09-05 |
2011-05-15 |
Gen Hospital Corp |
Polyacetal-arzneimittelkonjugate als freisetzungssystem
|
US7744861B2
(en)
|
2003-09-17 |
2010-06-29 |
Nektar Therapeutics |
Multi-arm polymer prodrugs
|
US8394365B2
(en)
|
2003-09-17 |
2013-03-12 |
Nektar Therapeutics |
Multi-arm polymer prodrugs
|
MXPA06003619A
(es)
*
|
2003-09-30 |
2008-01-14 |
New River Pharmaceuticals Inc |
Composiciones farmaceuticas para prevencion de sobredosis o abuso.
|
AU2004297228A1
(en)
|
2003-12-03 |
2005-06-23 |
Nektar Therapeutics Al, Corporation |
Method of preparing maleimide functionalized polymers
|
US9050378B2
(en)
|
2003-12-10 |
2015-06-09 |
Board Of Regents, The University Of Texas System |
N2S2 chelate-targeting ligand conjugates
|
ITTO20040056A1
(it)
*
|
2004-02-05 |
2004-05-05 |
Sorin Biomedica Cardio Spa |
Stent per l'erogazione endoliminale di principi o agenti attivi
|
JP5396019B2
(ja)
*
|
2004-03-11 |
2014-01-22 |
フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
ヒドロキシアルキルデンプンとタンパク質とのコンジュゲート
|
CN101659704A
(zh)
|
2004-03-11 |
2010-03-03 |
弗雷泽纽斯卡比德国有限公司 |
通过还原氨基化制备的羟烷基淀粉和蛋白质的偶联物
|
GB0406445D0
(en)
*
|
2004-03-23 |
2004-04-28 |
Astrazeneca Ab |
Combination therapy
|
US7705036B2
(en)
|
2004-04-01 |
2010-04-27 |
Cardiome Pharma Corp. |
Deuterated aminocyclohexyl ether compounds and processes for preparing same
|
US7786119B2
(en)
|
2004-04-01 |
2010-08-31 |
Cardiome Pharma Corp. |
Drug conjugates of ion channel modulating compounds
|
KR20050099311A
(ko)
*
|
2004-04-09 |
2005-10-13 |
에이엔에이치 케어연구소(주) |
주사제용 항암제 조성물
|
WO2006004429A2
(en)
*
|
2004-07-02 |
2006-01-12 |
Ge Healthcare As |
Imaging agents comprising a non- peptidic vector linked to a fluorophore via a polyethylene glycol linker
|
CA2583700A1
(en)
*
|
2004-08-11 |
2006-02-23 |
Arqule, Inc. |
Quinone prodrug compositions and methods of use
|
US8614228B2
(en)
|
2004-08-11 |
2013-12-24 |
Arqule, Inc. |
Quinone prodrug compositions and methods of use
|
AU2005285953B2
(en)
|
2004-09-22 |
2011-01-20 |
Nippon Kayaku Kabushiki Kaisha |
Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
|
JP5159314B2
(ja)
|
2004-11-18 |
2013-03-06 |
カーディオム ファーマ コーポレイション |
アミノシクロヘキシルエーテル化合物の合成方法
|
WO2006068232A1
(ja)
|
2004-12-22 |
2006-06-29 |
Sapporo Medical University |
線維化抑制のための薬物担体および薬物担体キット
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
CN105288630A
(zh)
*
|
2005-02-18 |
2016-02-03 |
阿布拉科斯生物科学有限公司 |
治疗剂的组合和给予方式以及联合治疗
|
KR20070110902A
(ko)
*
|
2005-03-11 |
2007-11-20 |
프레제니우스 카비 도이치란트 게엠베하 |
비활성 출발 물질로부터 생물활성 당단백질의 생산
|
KR20080008364A
(ko)
*
|
2005-05-05 |
2008-01-23 |
헤모텍 아게 |
관 스텐트의 전면 코팅
|
US8574259B2
(en)
|
2005-05-10 |
2013-11-05 |
Lifescreen Sciences Llc |
Intravascular filter with drug reservoir
|
JP4954983B2
(ja)
|
2005-05-18 |
2012-06-20 |
ファーマサイエンス・インコーポレイテッド |
Birドメイン結合化合物
|
EP1915340B1
(de)
|
2005-06-15 |
2013-08-07 |
Cardiome Pharma Corp. |
Synthetisches verfahren zur herstellung von aminocyclohexyletherverbindungen
|
EP1915412B1
(de)
*
|
2005-07-19 |
2010-03-24 |
Nektar Therapeutics |
Verfahren zur herstellung von polymermaleimiden
|
JP2009513182A
(ja)
|
2005-07-21 |
2009-04-02 |
エフエムシー バイオポリマー エイエス |
急速溶解する生体適合性被覆物で被覆した医療用部材
|
ITPD20050242A1
(it)
|
2005-08-03 |
2007-02-04 |
Fidia Farmaceutici |
Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
|
RU2451510C2
(ru)
*
|
2005-08-31 |
2012-05-27 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Композиции и способы получения слаборастворимых в воде лекарственных средств с увеличенной стабильностью
|
BRPI0615292A8
(pt)
*
|
2005-08-31 |
2018-03-06 |
Abraxis Bioscience Llc |
composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
|
EP1762250A1
(de)
*
|
2005-09-12 |
2007-03-14 |
Fresenius Kabi Deutschland GmbH |
Konjugate welche durch chemische Ligation zwischen Hydroxyalkylstärken und aktiven Substanzen mit Bildung eines Thiazolidin-Ringes entstehen
|
EP1926780B1
(de)
|
2005-09-22 |
2013-08-14 |
Medivas, LLC |
Bis-( -amino)-diol-diester-haltige poly(esteramid) und poly(esterurethan)-zusammensetzungen und verwendungsverfahren
|
EP1933881B1
(de)
|
2005-09-22 |
2019-03-13 |
Medivas, LLC |
Feste polymer-abgabezusammensetzungen und anwendungsverfahren dafür
|
US7846445B2
(en)
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
CN100384419C
(zh)
*
|
2005-12-02 |
2008-04-30 |
菏泽睿鹰制药集团有限公司 |
一种埃坡霉素缓释植入组合物及应用
|
CA2631704A1
(en)
*
|
2005-12-05 |
2007-06-14 |
Nitto Denko Corporation |
Polyglutamate-amino acid conjugates and methods
|
PE20070701A1
(es)
*
|
2005-12-06 |
2007-07-20 |
Cell Therapeutics Inc |
Terapia contra el cancer con estrogeno
|
EP1971372B1
(de)
|
2005-12-19 |
2018-11-14 |
PharmaIN Corporation |
Trägerzusammensetzungen mit hydrophobem kern zur abgabe von therapeutischen mitteln, herstellungs- und anwendungsverfahren damit
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
US8834912B2
(en)
*
|
2005-12-30 |
2014-09-16 |
Boston Scientific Scimed, Inc. |
Medical devices having multiple charged layers
|
US7910152B2
(en)
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
KR20080106254A
(ko)
*
|
2006-03-28 |
2008-12-04 |
니폰 가야꾸 가부시끼가이샤 |
탁산류의 고분자 결합체
|
US8758723B2
(en)
|
2006-04-19 |
2014-06-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for cellular imaging and therapy
|
CA2649335A1
(en)
*
|
2006-05-03 |
2007-11-08 |
I.Q.A., A.S. |
Pharmaceutical composition containing a taxane derivative, destined for the preparation of an infusion solution, method of preparation thereof and use thereof
|
EP2024362A4
(de)
|
2006-05-16 |
2012-01-25 |
Pharmascience Inc |
An die iap-bir-domäne bindende verbindungen
|
WO2007135910A1
(ja)
*
|
2006-05-18 |
2007-11-29 |
Nippon Kayaku Kabushiki Kaisha |
ポドフィロトキシン類の高分子結合体
|
US20080051603A1
(en)
|
2006-06-15 |
2008-02-28 |
Cell Therapeutics, Inc. |
Process for the preparation of poly-alpha-glutamic acid and derivatives thereof
|
CA2656077C
(en)
|
2006-06-15 |
2014-12-09 |
Marc Mckennon |
A process for the preparation of poly-alpha-glutamic acid and derivatives thereof
|
EP1867657A1
(de)
|
2006-06-15 |
2007-12-19 |
Cell Therapeutics Europe S.R.L. |
Verfahren zur Herstellung von Alpha-Poly(Glutaminsaüre) und seinen Derivaten
|
US20070298069A1
(en)
*
|
2006-06-26 |
2007-12-27 |
Boston Scientific Scimed, Inc. |
Medical devices for release of low solubility therapeutic agents
|
WO2008005538A2
(en)
*
|
2006-07-05 |
2008-01-10 |
Exelixis, Inc. |
Methods of using igf1r and abl kinase modulators
|
WO2008026048A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Wockhardt Research Centre |
Stable injectable pharmaceutical compositions of docetaxel
|
CA2664852A1
(en)
*
|
2006-10-03 |
2008-04-10 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of resorcinol derivatives
|
US10925977B2
(en)
*
|
2006-10-05 |
2021-02-23 |
Ceil>Point, LLC |
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
|
US20080086195A1
(en)
*
|
2006-10-05 |
2008-04-10 |
Boston Scientific Scimed, Inc. |
Polymer-Free Coatings For Medical Devices Formed By Plasma Electrolytic Deposition
|
US8334364B2
(en)
*
|
2006-11-06 |
2012-12-18 |
Nipon Kayaku Kabushiki Kaisha |
High-molecular weight derivative of nucleic acid antimetabolite
|
EP2090607B1
(de)
*
|
2006-11-08 |
2015-05-20 |
Nippon Kayaku Kabushiki Kaisha |
Polymerderivat eines nukleinsäuremetabolismus-antagonisten
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8430055B2
(en)
|
2008-08-29 |
2013-04-30 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
US8414525B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414909B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
KR100847123B1
(ko)
*
|
2006-11-22 |
2008-07-18 |
주식회사 스텐다드싸이텍 |
스텐트
|
WO2008066902A2
(en)
|
2006-11-30 |
2008-06-05 |
Nektar Therapeutics Al, Corporation |
Method for preparing a polymer conjugate
|
CN101209350B
(zh)
*
|
2006-12-30 |
2011-09-07 |
中国人民解放军军事医学科学院毒物药物研究所 |
以氨基酸为连接子的多聚谷氨酸-药物偶合物
|
CA2673991C
(en)
|
2007-01-21 |
2012-02-07 |
Hemoteq Ag |
Methods for coating catheter balloons with a defined quantity of active agent
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
US20080181852A1
(en)
*
|
2007-01-29 |
2008-07-31 |
Nitto Denko Corporation |
Multi-functional Drug Carriers
|
EP1967854B8
(de)
|
2007-03-06 |
2010-12-29 |
Cell Therapeutics, Inc. |
Verfahren zur Bestimmung der Menge konjugierten Taxans in Polyglutaminsäure-Taxan-Konjugaten
|
US8784866B2
(en)
|
2007-03-26 |
2014-07-22 |
William Marsh Rice University |
Water-soluble carbon nanotube compositions for drug delivery and medicinal applications
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
WO2008124735A2
(en)
*
|
2007-04-10 |
2008-10-16 |
Nitto Denko Corporation |
Multi-functional polyglutamate drug carriers
|
WO2008134528A1
(en)
*
|
2007-04-25 |
2008-11-06 |
Board Of Regents, The University Of Texas System |
Anti-cancer agent-hyaluronic acid conjugate compositions and methods
|
EP2152686B1
(de)
|
2007-04-30 |
2014-12-17 |
ArQule, Inc. |
Hydroxysulfonat aus chinonverbindungen und verwendung
|
JP5341879B2
(ja)
|
2007-05-09 |
2013-11-13 |
日東電工株式会社 |
疎水性化合物及びポリアミノ酸複合体を含む組成物
|
JP2010526917A
(ja)
*
|
2007-05-09 |
2010-08-05 |
日東電工株式会社 |
複数種の薬物を有するポリグルタミン酸塩複合体及びポリグルタミン酸塩−アミノ酸複合体
|
US20080279782A1
(en)
*
|
2007-05-09 |
2008-11-13 |
Nitto Denko Corporation |
Polymers conjugated with platinum drugs
|
US8252361B2
(en)
*
|
2007-06-05 |
2012-08-28 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices for local and regional treatment
|
KR101554250B1
(ko)
|
2007-06-11 |
2015-09-18 |
알. 로치 맥도날드 |
뇌혈관 연축의 예방을 위한 약물 전달 시스템
|
US10092524B2
(en)
|
2008-06-11 |
2018-10-09 |
Edge Therapeutics, Inc. |
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
|
US9192697B2
(en)
|
2007-07-03 |
2015-11-24 |
Hemoteq Ag |
Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
JP2010536341A
(ja)
|
2007-08-15 |
2010-12-02 |
アムニクス, インコーポレイテッド |
生物学的に活性なポリペプチドの特性を改変するための組成物および方法
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
CA2698812A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
WO2009041570A1
(ja)
*
|
2007-09-28 |
2009-04-02 |
Nippon Kayaku Kabushiki Kaisha |
ステロイド類の高分子結合体
|
WO2009070380A2
(en)
*
|
2007-10-03 |
2009-06-04 |
William Marsh Rice University |
Water-soluble carbon nanotube compositions for drug delivery and medical applications
|
EP2070951A1
(de)
*
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Verfahren zur Herstellung eines Hydroxyalkylstärkederivats mit zwei Linkern
|
US20090169480A1
(en)
*
|
2007-12-31 |
2009-07-02 |
Industrial Technology Research Institute |
Dendritic polymers and magnetic resonance imaging contrast agent employing the same
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
US8101706B2
(en)
|
2008-01-11 |
2012-01-24 |
Serina Therapeutics, Inc. |
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
|
CN102083468A
(zh)
*
|
2008-03-06 |
2011-06-01 |
日东电工株式会社 |
用于治疗癌症的聚合物紫杉醇结合物和方法
|
US8920788B2
(en)
*
|
2008-03-18 |
2014-12-30 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of physiologically active substances
|
CN101569747B
(zh)
*
|
2008-04-30 |
2012-08-22 |
宁波大学 |
一种聚乙二醇为载体的紫杉醇的前药制备方法
|
CN101569748B
(zh)
*
|
2008-04-30 |
2012-08-22 |
宁波大学 |
一种水溶性的紫杉醇的前药制备方法
|
EP3159033B1
(de)
*
|
2008-05-01 |
2019-02-27 |
Bayer Intellectual Property GmbH |
Wirkstoffhafttechniken und verfahren für katheterballon
|
EP2284209B1
(de)
|
2008-05-08 |
2016-08-31 |
Nippon Kayaku Kabushiki Kaisha |
Polymerkonjugat aus folsäure oder einem folsäurederivat
|
JP2011162569A
(ja)
*
|
2008-05-23 |
2011-08-25 |
Nano Career Kk |
カンプトテシン高分子誘導体及びその用途
|
KR20110051214A
(ko)
*
|
2008-07-30 |
2011-05-17 |
닛토덴코 가부시키가이샤 |
약물 담체
|
CA2732508C
(en)
|
2008-08-11 |
2016-03-15 |
Nektar Therapeutics |
Multi-arm polymeric alkanoate conjugates
|
HUE047352T2
(hu)
|
2008-09-23 |
2020-04-28 |
Nektar Therapeutics |
Eljárás ütemezett beadásra kamptotecin elõgyógyszerekkel (például PEG-ironotekánnal)
|
US8049061B2
(en)
|
2008-09-25 |
2011-11-01 |
Abbott Cardiovascular Systems, Inc. |
Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery
|
US8076529B2
(en)
|
2008-09-26 |
2011-12-13 |
Abbott Cardiovascular Systems, Inc. |
Expandable member formed of a fibrous matrix for intraluminal drug delivery
|
US8226603B2
(en)
|
2008-09-25 |
2012-07-24 |
Abbott Cardiovascular Systems Inc. |
Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery
|
US9050070B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8784384B2
(en)
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Frozen compositions and array devices thereof
|
US9060926B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8731841B2
(en)
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060934B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9050251B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8849441B2
(en)
|
2008-10-31 |
2014-09-30 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
US8788211B2
(en)
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
|
US8731840B2
(en)
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9072688B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9050317B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8545806B2
(en)
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US8762067B2
(en)
|
2008-10-31 |
2014-06-24 |
The Invention Science Fund I, Llc |
Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
|
US9072799B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8725420B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8793075B2
(en)
|
2008-10-31 |
2014-07-29 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8721583B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9060931B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US20100111841A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Searete Llc |
Compositions and methods for surface abrasion with frozen particles
|
US20100111857A1
(en)
|
2008-10-31 |
2010-05-06 |
Boyden Edward S |
Compositions and methods for surface abrasion with frozen particles
|
CL2009002167A1
(es)
|
2008-12-10 |
2010-10-15 |
Mersana Therapeutics Inc |
Formulacion farmaceutica para administracion endovenosa que comprende un compuesto derivado de conjugados de camptotecina-polimero biocompatibles y biodegradables, un agente de estabilizacion, uno o varios tampones y un tensoactivo, util para el tratamiento del cancer.
|
DK2393828T3
(en)
|
2009-02-03 |
2017-01-23 |
Amunix Operating Inc |
Extended recombinant polypeptides and compositions comprising same
|
US8703717B2
(en)
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
US8680050B2
(en)
|
2009-02-03 |
2014-03-25 |
Amunix Operating Inc. |
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
|
CN102421827B
(zh)
|
2009-05-15 |
2014-07-30 |
日本化药株式会社 |
具有羟基的生理活性物质的高分子结合体
|
US9849188B2
(en)
|
2009-06-08 |
2017-12-26 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
ES2705249T3
(es)
|
2009-06-08 |
2019-03-22 |
Amunix Operating Inc |
Polipéptidos reguladores de glucosa y métodos para su producción y uso
|
US10369256B2
(en)
|
2009-07-10 |
2019-08-06 |
Boston Scientific Scimed, Inc. |
Use of nanocrystals for drug delivery from a balloon
|
US10080821B2
(en)
|
2009-07-17 |
2018-09-25 |
Boston Scientific Scimed, Inc. |
Nucleation of drug delivery balloons to provide improved crystal size and density
|
US20120263701A1
(en)
|
2009-08-24 |
2012-10-18 |
Volker Schellenberger |
Coagulation factor vii compositions and methods of making and using same
|
JP6220126B2
(ja)
*
|
2009-11-23 |
2017-10-25 |
セルリアン・ファーマ・インコーポレイテッド |
治療的送達のためのシクロデキストリンに基づく重合体
|
WO2011081712A1
(en)
*
|
2009-12-31 |
2011-07-07 |
Boston Scientific Scimed, Inc. |
Cryo activated drug delivery and cutting balloons
|
US9284350B2
(en)
|
2010-02-12 |
2016-03-15 |
Pharmascience Inc. |
IAP BIR domain binding compounds
|
WO2011119536A1
(en)
|
2010-03-22 |
2011-09-29 |
Abbott Cardiovascular Systems Inc. |
Stent delivery system having a fibrous matrix covering with improved stent retention
|
KR20130028727A
(ko)
|
2010-03-29 |
2013-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
SG10201906075VA
(en)
|
2010-03-29 |
2019-08-27 |
Abraxis Bioscience Llc |
Methods of treating cancer
|
WO2011123830A2
(en)
|
2010-04-02 |
2011-10-06 |
Amunix Operating Inc. |
Alpha 1-antitrypsin compositions and methods of making and using same
|
DE102010022588A1
(de)
|
2010-05-27 |
2011-12-01 |
Hemoteq Ag |
Ballonkatheter mit einer partikelfrei Wirkstoff-abgebenden Beschichtung
|
SG186112A1
(en)
|
2010-06-04 |
2013-01-30 |
Abraxis Bioscience Llc |
Methods of treatment of pancreatic cancer
|
US20140073778A9
(en)
|
2010-07-09 |
2014-03-13 |
Fresenius Kabi Deutschland Gmbh |
Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
|
EP2590678A1
(de)
|
2010-07-09 |
2013-05-15 |
Fresenius Kabi Deutschland GmbH |
Konjugate mit hydroxyalkylstärke und einem zytotoxischen mittel sowie verfahren zu ihrer herstellung
|
EP2590680A1
(de)
|
2010-07-09 |
2013-05-15 |
Fresenius Kabi Deutschland GmbH |
Konjugate mit hydroxyalkylstärke und einem zytotoxischen mittel sowie verfahren zu ihrer herstellung
|
CA2804545A1
(en)
|
2010-07-09 |
2012-01-12 |
Fresenius Kabi Deutschland Gmbh |
Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
|
CN102339813A
(zh)
|
2010-07-14 |
2012-02-01 |
中国科学院微电子研究所 |
半导体结构及其制造方法
|
WO2012031236A1
(en)
|
2010-09-02 |
2012-03-08 |
Boston Scientific Scimed, Inc. |
Coating process for drug delivery balloons using heat-induced rewrap memory
|
KR20140024833A
(ko)
|
2010-11-17 |
2014-03-03 |
니폰 가야꾸 가부시끼가이샤 |
신규한 시티딘계 대사길항제의 고분자 유도체
|
WO2012088422A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
CN107115270A
(zh)
|
2011-02-11 |
2017-09-01 |
优势医疗公司 |
用于改善患有蛛网膜下腔出血的人的预后的组合物和方法
|
KR101328660B1
(ko)
*
|
2011-02-28 |
2013-11-14 |
부산대학교 산학협력단 |
항암제 소라페닙을 담지한 폴리카프로락톤 고분자담지체 및 이를 이용한 약물조절 방출형 스텐트
|
KR101302698B1
(ko)
*
|
2011-02-28 |
2013-09-03 |
부산대학교 산학협력단 |
폴리하이드록시옥타노에이트와 생분해성 고분자의 블락공중합체 합성에 의한 약물담지체와 이를 이용한 비혈관계 약물방출형 치료용 스텐트.
|
KR101302703B1
(ko)
|
2011-02-28 |
2013-09-03 |
부산대학교 산학협력단 |
폴리하이드록시옥타노에이트와 생분해성 고분자의 그라프트공중합체 합성에 의한 약물담지체와 이를 이용한 비혈관계 약물방출형 치료용 스텐트
|
KR20140052992A
(ko)
|
2011-04-05 |
2014-05-07 |
에쥐 세라피틱스, 인코포레이티드 |
뇌혈류에 영향을 미치는 뇌손상 후 결과를 개선시키기 위한 뇌실내 약물 전달 시스템
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
EP3159368A1
(de)
|
2011-06-23 |
2017-04-26 |
DSM IP Assets B.V. |
Neue biologisch abbaubare polyesteramid-copolymere zur arzneimittelabgabe
|
CN102850301A
(zh)
*
|
2011-06-28 |
2013-01-02 |
中国人民解放军军事医学科学院毒物药物研究所 |
水溶性紫杉醇衍生物及其药物组合物及其医药用途
|
WO2013022458A1
(en)
|
2011-08-05 |
2013-02-14 |
Boston Scientific Scimed, Inc. |
Methods of converting amorphous drug substance into crystalline form
|
WO2013028208A1
(en)
|
2011-08-25 |
2013-02-28 |
Boston Scientific Scimed, Inc. |
Medical device with crystalline drug coating
|
RU2623426C2
(ru)
|
2011-09-11 |
2017-06-26 |
Ниппон Каяку Кабусики Кайся |
Способ получения блок-сополимера
|
CN103083680B
(zh)
|
2011-11-07 |
2014-12-24 |
北京键凯科技有限公司 |
聚乙二醇-氨基酸寡肽-依诺替康药物结合物及其药物组合物
|
US10370430B2
(en)
|
2012-02-15 |
2019-08-06 |
Bioverativ Therapeutics Inc. |
Recombinant factor VIII proteins
|
SG11201404885RA
(en)
|
2012-02-15 |
2014-09-26 |
Amunix Operating Inc |
Factor viii compositions and methods of making and using same
|
EP3406347A3
(de)
|
2012-02-27 |
2019-02-13 |
Amunix Operating Inc. |
Xten-konjugat-zusammensetzungen und verfahren zur herstellung davon
|
WO2013146381A1
(ja)
*
|
2012-03-27 |
2013-10-03 |
テルモ株式会社 |
薬剤コート層およびこれを有する医療機器
|
SI2833905T1
(en)
|
2012-04-04 |
2018-08-31 |
Halozyme, Inc. |
Combination therapy with hyaluronidase and tumane-directed taxane
|
CN102614110B
(zh)
*
|
2012-04-27 |
2013-12-25 |
北京大学 |
稳定的聚乙二醇化药物型胶束组合物及其制备方法
|
US9399019B2
(en)
|
2012-05-09 |
2016-07-26 |
Evonik Corporation |
Polymorph compositions, methods of making, and uses thereof
|
CN102702140B
(zh)
*
|
2012-06-19 |
2014-05-14 |
中国医学科学院生物医学工程研究所 |
一种水溶性紫杉醇化合物的制备方法及用途
|
CN102731442B
(zh)
*
|
2012-07-18 |
2014-06-11 |
中国医学科学院生物医学工程研究所 |
一种水溶性多烯紫杉醇化合物的制备方法及用途
|
WO2014055493A1
(en)
|
2012-10-02 |
2014-04-10 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
DK2925718T3
(en)
|
2012-11-30 |
2018-10-22 |
Novomedix Llc |
SUBSTITUTED BIARYL SULPHONAMIDS AND USE THEREOF
|
US9993427B2
(en)
|
2013-03-14 |
2018-06-12 |
Biorest Ltd. |
Liposome formulation and manufacture
|
WO2014182542A1
(en)
|
2013-05-06 |
2014-11-13 |
Abbott Cardiovascular Systems Inc. |
A hollow stent filled with a therapeutic agent formulation
|
CN103263675B
(zh)
*
|
2013-05-16 |
2015-02-11 |
湘潭大学 |
一种聚ε-己内酯负载的抗肿瘤前药及其制备方法
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
CN104721830A
(zh)
*
|
2013-12-20 |
2015-06-24 |
北京蓝贝望生物医药科技股份有限公司 |
Top肽
|
US10434071B2
(en)
|
2014-12-18 |
2019-10-08 |
Dsm Ip Assets, B.V. |
Drug delivery system for delivery of acid sensitivity drugs
|
WO2016187147A1
(en)
*
|
2015-05-15 |
2016-11-24 |
Fl Therapeutics Llc |
Docetaxel and human serum albumin complexes
|
KR101726728B1
(ko)
*
|
2015-07-28 |
2017-04-14 |
주식회사 삼양바이오팜 |
고분자 담체 함유 약학 조성물의 유연물질 분석 방법
|
AU2016301303B2
(en)
|
2015-08-03 |
2021-10-07 |
Bioverativ Therapeutics Inc. |
Factor IX fusion proteins and methods of making and using same
|
KR20180038560A
(ko)
|
2015-08-28 |
2018-04-16 |
아뮤닉스 오퍼레이팅 인코포레이티드 |
키메라 폴리펩티드 조립체와 이의 제조 및 사용 방법
|
CN106554330B
(zh)
*
|
2015-09-26 |
2019-07-05 |
南京友怡医药科技有限公司 |
水溶性多西他赛抗癌药物化合物及其制备方法和应用
|
CN106554329B
(zh)
*
|
2015-09-26 |
2019-07-05 |
南京友怡医药科技有限公司 |
水溶性紫杉醇抗癌药物化合物及其制备方法和应用
|
WO2017193757A1
(zh)
*
|
2016-05-10 |
2017-11-16 |
浙江海正药业股份有限公司 |
水溶性Epothilone衍生物及其制备方法
|
CN109415378B
(zh)
*
|
2016-05-10 |
2021-11-09 |
浙江海正药业股份有限公司 |
水溶性Epothilone衍生物及其制备方法
|
CN108478804B
(zh)
*
|
2018-05-08 |
2020-09-22 |
辽宁大学 |
一种聚丙烯酸-s-s-药物共聚物及其制备方法
|
US20190351031A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
JP2022523672A
(ja)
*
|
2019-01-28 |
2022-04-26 |
ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム |
がんを治療するための金属キレート化剤併用療法
|
CN112604002A
(zh)
*
|
2020-07-12 |
2021-04-06 |
苏州裕泰医药科技有限公司 |
二硫键桥连的多西他赛-脂肪酸前药及其自组装纳米粒
|
WO2022026867A1
(en)
*
|
2020-07-31 |
2022-02-03 |
Cedars-Sinai Medical Center |
Glutamine as an anticancer therapy in solid tumors
|